Literature DB >> 6930680

Heterogeneity of human high density lipoprotein: presence of lipoproteins with and without apoE and their roles as substrates for lecithin:cholesterol acyltransferase reaction.

Y L Marcel, C Vezina, D Emond, G Suzue.   

Abstract

By affinity chromatography on heparin-Sepharose, two classes of lipoproteins were separated from high density lipoproteins (HDL) isolated from patients with primary or secondary lecithin:cholesterol acyltransferase (LCATase; EC 2.3.1.43) deficiency and from normal subjects. The unretained fraction, HDL(A), was characterized by having apoA-I as a major apoprotein; it also contained apoA-II, -C-II, and -C-III but it contained only traces of immunodetectable apoE and no apoB. The retained fraction, HDL(E), had apoE as the major apoprotein; it also contained apoA-I, -A-II, -B, -C-II, and -C-III. The relative concentration of apoA-I increased with increasing density in the HDL(E) subclass. Compared to HDL(A), HDL(E) had a significantly higher cholesterol content and a lower protein concentration. HDL(E) was mainly (90%) contained within the HDL(2) subfraction. Contamination of HDL(E) by low density lipoproteins (LDL) or Lp(a) was minimal on the basis of pre-beta-electrophoretic mobility and absence of albumin, respectively. Contamination by LDL or Lp(a) could be resolved in part by application of HDL(E) to concanavalin A-Sepharose or to heparin-Sepharose with a shallow gradient. When evaluated as substrates for a highly purified LCATase preparation, the initial reaction rates and V(max) obtained with HDL(A) were always higher than those obtained with HDL(E) in any given plasma. However, both HDL subclasses from LCATase-deficient subjects were better substrates than the corresponding HDL subclasses from normal plasma. Also, both HDL(3A) and HDL(3E) isolated from normal HDL(3) were better substrates than the corresponding subclasses isolated from normal HDL(2). The recognition of this compositional and functional heterogeneity within HDL will allow a better understanding of the metabolism of this lipoprotein class.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6930680      PMCID: PMC349528          DOI: 10.1073/pnas.77.5.2969

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  The heterogeneity of rat high density lipoproteins.

Authors:  S H Quarfordt; R S Jain; L Jakoi; S Robinson; F Shelburne
Journal:  Biochem Biophys Res Commun       Date:  1978-08-14       Impact factor: 3.575

2.  Identification of nascent high density lipoproteins containing arginine-rich protein in human plasma.

Authors:  J B Ragland; P D Bertram; S M Sabesin
Journal:  Biochem Biophys Res Commun       Date:  1978-01-13       Impact factor: 3.575

3.  A rapid electrophoretic technique for identification of subunit species of apoproteins in serum lipoproteins.

Authors:  J P Kane
Journal:  Anal Biochem       Date:  1973-06       Impact factor: 3.365

4.  Protein and carbohydrate composition of Lp(a)lipoprotein from human plasma.

Authors:  C Ehnholm; H Garoff; O Renkonen; K Simons
Journal:  Biochemistry       Date:  1972-08-15       Impact factor: 3.162

Review 5.  Practical methods for plasma lipoprotein analysis.

Authors:  F T Hatch
Journal:  Adv Lipid Res       Date:  1968

6.  Human intestinal lipoproteins. Studies in chyluric subjects.

Authors:  P H Green; R M Glickman; C D Saudek; C B Blum; A R Tall
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

7.  Preparative isoelectric focussing of apolipoproteins C and E from human very low density lipoproteins.

Authors:  Y L Marcel; M Bergseth; A C Nestruck
Journal:  Biochim Biophys Acta       Date:  1979-04-27

8.  The interaction of heparin with an apoprotein of human very low density lipoprotein.

Authors:  F A Shelburne; S H Quarfordt
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

9.  Forms of human serum high density lipoprotein protein.

Authors:  A Scanu
Journal:  J Lipid Res       Date:  1966-03       Impact factor: 5.922

10.  Studies on the polymorphism of human apolipoprotein A-I.

Authors:  A C Nestruck; G Suzue; Y L Marcel
Journal:  Biochim Biophys Acta       Date:  1980-01-18
View more
  6 in total

1.  Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency.

Authors:  S Yamashita; D L Sprecher; N Sakai; Y Matsuzawa; S Tarui; D Y Hui
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

2.  High-density lipoprotein subpopulations as substrates for the transfer of cholesteryl esters to very-low-density lipoproteins.

Authors:  M A Lasunción; A Iglesias; N Skottová; E Orozco; E Herrera
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

3.  Characteristics of human lipoproteins isolated by selected-affinity immunosorption of apolipoprotein A-I.

Authors:  J P McVicar; S T Kunitake; R L Hamilton; J P Kane
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

4.  Role of apolipoprotein E-containing lipoproteins in abetalipoproteinemia.

Authors:  C B Blum; R J Deckelbaum; L D Witte; A R Tall; J Cornicelli
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

5.  Apolipoprotein M expression increases the size of nascent pre beta HDL formed by ATP binding cassette transporter A1.

Authors:  Anny Mulya; Jeongmin Seo; Amanda L Brown; Abraham K Gebre; Elena Boudyguina; Gregory S Shelness; John S Parks
Journal:  J Lipid Res       Date:  2009-09-18       Impact factor: 5.922

6.  Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.

Authors:  D J Rader; K Ikewaki; N Duverger; H Schmidt; H Pritchard; J Frohlich; M Clerc; M F Dumon; T Fairwell; L Zech
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.